{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:01:57Z","timestamp":1781726517162,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ejim.2009.09.001","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T08:09:25Z","timestamp":1254125365000},"page":"744-748","source":"Crossref","is-referenced-by-count":39,"title":["Prevention of strongyloides hyperinfection syndrome: A rheumatological point of view"],"prefix":"10.1016","volume":"20","author":[{"given":"Mittermayer","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejim.2009.09.001_bib1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1345\/aph.1K302","article-title":"Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection","volume":"41","author":"Segarra-Newnham","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ejim.2009.09.001_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/RHU.0b013e3180690933","article-title":"Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy","volume":"13","author":"Krishnamurthy","year":"2007","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.ejim.2009.09.001_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archderm.1958.01560080044007","article-title":"Larva currens; a distinctive variant of cutaneous larva migrans due to Strongyloides stercoralis","volume":"78","author":"Arthur","year":"1958","journal-title":"AMA Arch Derm"},{"issue":"1","key":"10.1016\/j.ejim.2009.09.001_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","author":"Keiser","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.ejim.2009.09.001_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2006.01.016","article-title":"Severe strongyloidiasis in corticosteroid-treated patients","volume":"54","author":"Fardet","year":"2007","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.ejim.2009.09.001_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JCM.01735-06","article-title":"Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans","volume":"45","author":"van Doorn","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ejim.2009.09.001_bib7","first-page":"663","article-title":"Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study","volume":"87","author":"Portugal","year":"2002","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.ejim.2009.09.001_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1258\/004947505774938558","article-title":"Comparison of albendazole regimen for prophylaxis of strongyloides hyperinfection in nephrotic syndrome patients on long-term steroids in Cambodia","volume":"35","author":"Leang","year":"2005","journal-title":"Trop Doct"},{"issue":"3","key":"10.1016\/j.ejim.2009.09.001_bib9","first-page":"191","article-title":"Albendazole is effective treatment for chronic strongyloidiasis","volume":"86","author":"Archibald","year":"1993","journal-title":"Q J Med"},{"issue":"5","key":"10.1016\/j.ejim.2009.09.001_bib10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/clinids\/17.5.900","article-title":"Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS","volume":"17","author":"Torres","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ejim.2009.09.001_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0035-9203(94)90110-4","article-title":"Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases","volume":"88","author":"Datry","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.ejim.2009.09.001_bib12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/169.5.1076","article-title":"A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis","volume":"169","author":"Gann","year":"1994","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ejim.2009.09.001_bib13","first-page":"735","article-title":"A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis","volume":"26","author":"Pitisuttithum","year":"1995","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"5","key":"10.1016\/j.ejim.2009.09.001_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","article-title":"A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children","volume":"55","author":"Marti","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ejim.2009.09.001_bib15","first-page":"147","article-title":"Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan","volume":"31","author":"Toma","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"10.1016\/j.ejim.2009.09.001_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s101560200013","article-title":"Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2weeks apart","volume":"8","author":"Zaha","year":"2002","journal-title":"J Infect Chemother"},{"issue":"6","key":"10.1016\/j.ejim.2009.09.001_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10156-004-0345-Z","article-title":"Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody","volume":"10","author":"Zaha","year":"2004","journal-title":"J Infect Chemother"},{"issue":"12","key":"10.1016\/j.ejim.2009.09.001_bib18","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1517\/14656566.5.12.2615","article-title":"Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis","volume":"5","author":"Igual-Adell","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.ejim.2009.09.001_bib19","first-page":"442","article-title":"Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole","volume":"36","author":"Nontasut","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"Suppl 3","key":"10.1016\/j.ejim.2009.09.001_bib20","first-page":"32","article-title":"Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis","volume":"37","author":"Singthong","year":"2006","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"10.1016\/j.ejim.2009.09.001_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijantimicag.2007.08.014","article-title":"Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis","volume":"31","author":"Suputtamongkol","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.ejim.2009.09.001_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/clinids\/21.3.675","article-title":"Strongyloidiasis in patients with hematologic malignancies","volume":"21","author":"Nucci","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ejim.2009.09.001_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0378-6323.16795","article-title":"Preventing strongyloidiasis in the immunosuppressed","volume":"71","author":"Rao","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.ejim.2009.09.001_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archinte.144.2.321","article-title":"Risk factors for strongyloidiasis. A case\u2013control study","volume":"144","author":"Davidson","year":"1984","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.ejim.2009.09.001_bib25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1469-0691.2006.01443.x","article-title":"Severe strongyloidiasis in corticosteroid-treated patients","volume":"12","author":"Fardet","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.ejim.2009.09.001_bib26","first-page":"959","article-title":"Seroepidemiology of human T-cell lymphotropic virus type I\/II in northeastern Brazil","volume":"6","author":"Moreira","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.ejim.2009.09.001_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4269\/ajtmh.2006.74.246","article-title":"Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection","volume":"74","author":"Hirata","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.ejim.2009.09.001_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2169\/internalmedicine.39.695","article-title":"Strongyloidiasis\u2014progress in diagnosis and treatment","volume":"39","author":"Zaha","year":"2000","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2009.09.001_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.trstmh.2008.01.020","article-title":"Strongyloides hyperinfection syndrome: an emerging global infectious disease","volume":"102","author":"Marcos","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ejim.2009.09.001_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3949\/ccjm.65.8.436","article-title":"Rheumatologic manifestations of HIV-1 and HTLV-1 infections","volume":"65","author":"Vassilopoulos","year":"1998","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"10.1016\/j.ejim.2009.09.001_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1201-9712(02)90132-3","article-title":"Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection","volume":"6","author":"Terashima","year":"2002","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.ejim.2009.09.001_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.trstmh.2007.05.021","article-title":"Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases","volume":"101","author":"Ghosh","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.ejim.2009.09.001_bib33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/322707","article-title":"Diagnosis of Strongyloides stercoralis infection","volume":"33","author":"Siddiqui","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ejim.2009.09.001_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/gut.27.3.337","article-title":"Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy","volume":"27","author":"Ainley","year":"1986","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejim.2009.09.001_bib35","first-page":"526","article-title":"Prevention of opportunistic infections in immunosuppressed patients in the tropical top end of the Northern Territory","volume":"27","author":"Davis","year":"2003","journal-title":"Commun Dis Intell"},{"issue":"2","key":"10.1016\/j.ejim.2009.09.001_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/infdis\/163.2.376","article-title":"A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis","volume":"163","author":"Greene","year":"1991","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ejim.2009.09.001_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.trstmh.2005.12.006","article-title":"Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy","volume":"100","author":"Page","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.ejim.2009.09.001_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4269\/ajtmh.2001.65.346","article-title":"The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies","volume":"65","author":"Schaffel","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ejim.2009.09.001_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0732-8893(94)90129-5","article-title":"Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis","volume":"18","author":"Kobayashi","year":"1994","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362050900168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362050900168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:47:50Z","timestamp":1558561670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362050900168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S095362050900168X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2009.09.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}